ICGC Datasets on AWS
Datasets from the International Cancer Genomes Consortium are now available on Amazon Web Services. Specifically, the ICGC said that it has made 2,400 tumor/normal encrypted whole genome sequences from 1,200 unique donors available on the cloud where authorized cancer researchers will be able to access and analyze it.
Invitae Hereditary Cancer Testing Expansion
Invitae has announced an expansion of its hereditary cancer testing menu. Testing will now include blood, bone, brain, endocrine (hyperparathyroidism, thyroid cancer, and paraganglioma-pheochromocytoma), genitourinary (renal/urinary tract and prostate cancer), sarcoma, and skin cancers (melanoma and basal cell nevus syndrome). In addition, the company is introducing three new focused panels based entirely on oncology management guidelines in breast, gynecologic, and colon cancer. Invitae is also offering epidermal growth factor receptor testing for patients with a strong personal and family history of lung cancer. This expanded test menu is offered at the same price and with the same flexibility as all of Invitae’s genetic tests, the company said in a statement.
RiboCop rRNA Depletion Kit
Lexogen has launched RiboCop rRNA Depletion Kit. The kit enables the efficient removal of cytoplasmic 28S, 18S, 5.8S, 45S, 5S, as well as mitochondrial mt16S ribosomal RNA sequences in human samples for next-generation sequencing library preparation. The RiboCop protocol takes two hours to complete, according to the company's website. No enzymatic reactions or mechanical shearing are involved, leaving full-length transcripts intact for downstream processing. In addition, magnetic beads are used for depletion and purification steps which renders the protocol automation-friendly.
For more new products and services, please visit the New Products page on our website.